Asthma and lower airway diseasePreterm birth, infant weight gain, and childhood asthma risk: A meta-analysis of 147,000 European children
Key words
Abbreviations used
Cited by (0)
Supported by the European Community's Seventh Framework Programme FP7/2007-2013, project CHICOS. The research leading to these results has received funding from the European Respiratory Society and the European Community's Seventh Framework Programme FP7/2007-2013–Marie Curie Actions under grant agreement RESPIRE, PCOFUND-GA-2008-229571.
Disclosure of potential conflict of interest: I. Annesi-Maesano has received one or more grants from or has one or more grants pending with UE. S. H. Arshad has been supported by one or more grants from the National Institute of Health and Asthma UK and has received one or more payments for lecturing from or is on the speakers' bureau for Thermo Fisher and GlaxoSmithKline. H. Bisgaard has been supported by one or more grants from the Danish State Budget and the Lundbeck Foundation, has consultancy arrangements with Chiesi Pharmaceuticals, and has received one or more grants from or has one or more grants pending with the Danish Strategic Research Council, the Capital Region of Denmark, the Oticon Foundation, the European Research Council, and the Danish Council for Independent Research, Medical Sciences. C. Dogaru and C. E. Kuehni are employed by the University of Bern. M. Eggesbø has been supported by one or more grants from and has received support for travel from Chicos. A. J. Henderson has been supported by one or more grants from the Wellcome Trust and the Medical Research Council. H. M. Inskip has been supported by one or more grants from the UK Medical Research Council and many funding bodies and is a Board member for the UK Medical Research Council. T. Keil has received one or more grants from or has one or more grants pending with the European Commission. K. Lancz and L. Palkovicova have been supported by one or more grants from the NIH (NCI and Fogarty), the European Union, and the Slovak Ministry of Health. S. Lau has been supported by one or more grants from the German Research Foundation DFG, is a member of the Merck Drug monitoring committee, has consultancy arrangements with Allergopharma (Reinbek, Germany), has received one or more grants from or has one or more grants pending with Symbiopharm (Herborn, Germany), and has received one or more payments for lecturing from or is on the speakers' bureau for Symbiopharm, GlaxoSmithKline, CSL Behring. M. Mommers has been supported by one or more grants from the Netherlands Asthma Foundation and has received support for travel from the European Community Seventh Framework Programme. K. C. Pike has been supported by one or more grants from FSA BLF and has received various travel grants and bursaries, most recently from the European Respiratory Society. G. Roberts has been supported by one or more grants from the NIH and BMA. A. Schmidt has been supported by one or more grants from the Swiss National Science Foundation. C. Thijs has been supported by one or more grants from the Netherlands Asthma Foundation and has received support for travel from European Community's Seventh Framework Programme. M. Vrijheid has been supported by one or more grants from and has received support for travel from the European Community's Seventh Framework Programme FP7/2007-2013 (Project CHICOS). L. Duijts has received research support from the European Community's Seventh Framework Programme FP7/2007-2013 (Project CHICOS) and is the recipient of a European Respiratory Society/Marie Curie Joint Research Fellowship (no. MC 1226-2009). The rest of the authors declare that they have no relevant conflicts of interest.